Panel Discussion: Choosing the Best Indications to Maximize Benefit to Patients

Time: 11:45 am
day: Day One


• Indications that can generate best proof-of concept results and most impact on patients
• Clinical development strategies in various stages of disease progression and patient recruitment early in disease
• Understanding how current standard of care and in vivo Treg approaches can be combined to promote Treg function
• Comparing allogeneic and autologous Treg cell therapy approaches